Articles Gold Open Access (CC BY 4.0) 2,300 Views 440 Downloads

Oral health and chronic kidney disease: Findings from a descriptive survey in Lagos, Nigeria.

Abstract

Background: Chronic kidney disease (CKD) is a global public health problem, characterized by a progressive and irreversible decline in renal functions, and affecting up to 22.3% of Nigerians. Oral diseases are increasingly recognized to have a bidirectional relationship with CKD, contributing to systemic inflammation, infections, protein-energy wasting, and atherosclerotic complications. Given this interconnectedness, we aimed to explore the relationship between CKD and oral conditions among LASUTH patients to better understand and address these co-occurring health issues.

Methods: This descriptive observational study was conducted in the nephrology unit of LASUTH. Patients aged >20 years with a diagnosis of CKD were enlisted and a validated questionnaire with the modified WHO oral health status proforma was utilized to record clinical data: Estimated Glomerular Filtration Rate (EGFR), End-Stage Renal Disease (ESRD), Creatinine and Urinalysis from medical records and oral examination findings, Oral Hygiene Index-Simplified (OHI-S), Gingival Index (GI), Community Periodontal Index of Treatment needs (CPITN), oral malodour, and Oral lesions. Multivariate logistic regression analysis was conducted with adjustments for covariates like age, alcohol use, and BMI to determine the association between oral diseases and CKD. The significance level (p) was set at 0.05, with a confidence interval (CI) of 95%.

Results: A total of 200 patients at different stages of CKD were included. The age range was 22–83 years. The majority were aged 31-60 years (mean age 55.22 ± 14.35 years); 69% were males; 7% were current smokers while 12% currently drank alcohol; 27% had eGFR< 15 mL/min/1.73m2 (ESRD); 27% had Creatinine values >1.3mg/dl; prevalence of Gingivitis was 72%; periodontitis was 14% (CPI score ≥3: Pocket depth of ≥4 mm); and poor OHI was 22%. The commonest oral lesions were white lesions 2%, candidiasis 4.5%, hyperpigmentation 22%, oral ulcers 5%, hemorrhagic lesions 12.5%, and Oral malodor 74.5%. Multiple logistic regression analysis revealed significantly increased odds of ESRD among uneducated respondents (OR 1.194; CI: 0.832-1.713); those >60years (OR: 1.129; CI:0.436-2.923); current alcohol drinkers (OR:1.125; CI: 0.281-4.409); and smokers (OR:2.328; CI: 0.27-20.289). The odds of low stimulated saliva flow rate (OR: 1.181; CI:0.768-4.512), oral malodor (OR:1.093; CI: 0.763-1.565), and periodontal disease (OR: 1.242; CI: 0.698-2.209) were also significantly higher among those with ESRD.

Conclusion: Individuals with CKD and ESRD may have a higher prevalence of oral diseases and conditions. There were significantly increased odds of ESRD among uneducated respondents, those over 60, current alcohol consumers, and smokers. Additionally, the odds of low stimulated saliva flow rate, oral malodor, and periodontal disease was also significantly higher among those with ESRD. This relationship may also be bidirectional, highlighting the need for appropriate oral self-care and regular dental-care utilization in patients with renal disease. The findings underscore the need for integrated healthcare approaches that consider both oral and renal health, providing a foundation for further research and targeted interventions.

 

Keywords (MeSH)

Chronic kidney disease End Stage Renal Disease. Periodontitis Oral lesions Oral Health

References

  1. Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, et
  2. al. Change in albuminuria and subsequent risk of end-stage kidney disease: an
  3. individual participant-level consortium meta-analysis of observational studies.
  4. Lancet Diabetes Endocrinol. 2020 Oct;8(10):875-887.
  5. Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al.
  6. The epidemiology of chronic kidney disease in sub-Saharan Africa: a
  7. systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174–
  8. e81.
  9. Abd ElHafeez S, Bolignano D, D’Arrigo G, Dounousi E, Tripepi G,
  10. Zoccali C. Prevalence and burden of chronic kidney disease among the
  11. general population and high-risk groups in Africa: a systematic review.
  12. BMJ Open. 2018;8(1):e015069.
  13. Olanrewaju TO, Aderibigbe A, Popoola AA, Braimoh KT, Buhari MO,
  14. Adedoyin OT, et al; Ilorin Renal Study Group. Prevalence of chronic kidney
  15. disease and risk factors in North-Central Nigeria: a population-based
  16. survey. BMC Nephrol. 2020 Nov 10;21(1):467. doi: 10.1186/s12882-020-
  17. -8.
  18. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic
  19. kidney disease: global dimension and perspectives. Lancet. 2013 Jul
  20. ;382(9888):260-272.
  21. Tonelli, M.; Wiebe, N.; Culleton, B.; House, A.; Rabbat, C.; Fok, M.; McAlister, F.;
  22. Garg, A.X. Chronic Kidney Disease and Mortality Risk: A Systematic Review. J. Am. Soc.
  23. Nephrol. 2006, 17, 2034–2047.
  24. Levin A., Tonelli M., Bonventre J., Coresh J., Donner J.A., Fogo A.B.et
  25. al.. (2017) Global kidney health 2017 and beyond: a roadmap for closing
  26. gaps in care, research, and policy. Lancet 390, 1888–1917 10.1016/S0140-
  27. (17)30788-2.
  28. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, et al.
  29. Low-abundance biofilm species orchestrates inflammatory periodontal disease
  30. through the commensal microbiota and complement. Cell Host Microbe. 2012
  31. Nov 15;10(5):497-506.
  32. Oyapero A, Enone LL, Moronkola R, Ojikutu RO. Relationship between Periodontal Disease, Dental Caries and the Risk Indicators for Cardiovascular Disease in Lagos, Nigeria. West Afr J Med. 2023 Apr 28;40(4):404-413.
  33. Chapple IL, Genco R, Working group 2 of the joint EFP/AAP workshop.
  34. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP
  35. Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2017
  36. ;44(Suppl 18):S127-S135.
  37. U. El-Shinnawi, M. Soory Associations between periodontitis and
  38. systemic inflammatory diseases: response to treatment Recent Pat Endocr
  39. Metab Immune Drug Discov, 2013:7: 169-188.
  40. Nunn J., Sharp J., Lambert H., Plant N., & Coulthard M.. Oral health in children
  41. with renal disease. Pediatric Nephrology 2000;14(10-11):997-1001.
  42. https://doi.org/10.1007/s004670050061
  43. Han K. and Park J. Tooth loss and risk of end‐stage renal disease: a nationwide
  44. cohort study. Journal of Periodontology 2020;92(3):371-377.
  45. https://doi.org/10.1002/jper.19-0679
  46. Omotunde S Omotunde O. Oral hygiene practice, dental profile and dental
  47. service utilization of chronic kidney disease patients. Magna Scientia Advanced
  48. Research and Reviews 2022;4(1):068-077.
  49. https://doi.org/10.30574/msarr.2022.4.1.0028
  50. Akar H, Akar GC, Carrero JJ, et al. Systemic consequences of poor
  51. oral health in chronic kidney disease patients, Clin J Am Soc Nephrol 2011; 6: 218-226. 10.2215/CJN.05470610
  52. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA. 2004;291(4):451-9. doi: 10.1001/jama.291.4.451.
  53. Oyeyemi AL, Oyeyemi AY, Adegoke BO, Oyetoke FO. Pattern of noncommunicable diseases among medical admissions in Lagos University Teaching
  54. Hospital, Lagos, Nigeria. J Public Health Afr. 2019;10(1):1010.
  55. Arogundade FA, Sanusi AA, Hassan MO, Akinsola A. The pattern, clinical
  56. characteristics and outcome of ESRD in Ile-Ife, Nigeria: is there a change in
  57. trend? Afr Health Sci. 2011;11(4):594-601.
  58. Chukwuonye II, Ogah OS, Anyabolu EN, Ohagwu KA, Nwabuko OC, Onwuchekwa U, Chukwuonye ME, Obi EC, Oviasu E. Prevalence of chronic kidney disease in Nigeria: systematic review of population-based studies. Int J Nephrol Renovasc Dis. 2018; 11:165-172. doi: 10.2147/IJNRD.S162230.
  59. Inker LA, Levey AS, Pandya K, Stoycheff N, Okparavero A, Greene T; Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis. 2014;64(1):74-85. doi: 10.1053/j.ajkd.2014.02.020.
  60. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019;1165:3-15. doi: 10.1007/978-981-13-8871-2_1.
  61. Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, et al. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2016 ;27(7):2135-47. doi: 10.1681/ASN.2015050542.
  62. N.R. Hill, S.T. Fatoba, J.L. Oke, et al. Global prevalence of chronic kidney
  63. disease—a systematic review and meta-analysis PLoS One 2016;11: Article e0158765,
  64. 1371/journal.pone.0158765.
  65. Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and
  66. kidney disease: basic concepts and clinical implications. Nat Rev Immunol.
  67. ;13:738–53.
  68. Neish AS. Mucosal immunity and the microbiome. Ann Am Thorac
  69. Soc. 2014;11:S28–32.
  70. ong A, Evangelidis N, Kurnikowski A, Lewandowski M, Bretschneider P, Oberbauer R, Baumgart A, Scholes-Robertson N, Stamm T, Carrero JJ, Pecoits-Filho R, Hecking M. Nephrologists' Perspectives on Gender Disparities in CKD and Dialysis. Kidney Int Rep. 2021;7(3):424-435. doi: 10.1016/j.ekir.2021.10.022.
  71. Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151-164. doi: 10.1038/nrneph.2017.181.
  72. Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100 Suppl 1(Suppl 1):S186-96. doi: 10.2105/AJPH.2009.166082.
  73. G. Wolf, M. Busch, N. Müller, U.A. Müller. Association between socioeconomic
  74. status and renal function in a population of German patients with diabetic nephropathy
  75. treated at a tertiary centre. Nephrol Dial Transplant 2011;26: 4017-4023,
  76. 1093/ndt/gfr185
  77. Vart P, Grams ME, Ballew SH, Woodward M, Coresh J, Matsushita K. Socioeconomic status and risk of kidney dysfunction: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant. 2019; 34(8):1361-1368. doi: 10.1093/ndt/gfy142.
  78. Thio CHL, Vart P, Kieneker LM, Snieder H, Gansevoort RT, Bültmann U. Educational level and risk of chronic kidney disease: longitudinal data from the PREVEND study. Nephrol Dial Transplant. 2020; 35(7):1211-1218. doi: 10.1093/ndt/gfy361.
  79. Winitzki D, Zacharias HU, Nadal J, Baid-Agrawal S, Schaeffner E, Schmid M,
  80. et al.
  81. Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the
  82. German CKD (GCKD) Cohort. Kidney Int Rep. 2022 Feb 14;7(5):1004-1015. doi:
  83. 1016/j.ekir.2022.02.001. PMID: 35570994; PMCID: PMC9091575
  84. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking,
  85. and chronic kidney disease. Am J Epidemiol 2006; 164: 263–271.
  86. Perneger TV, Whelton PK, Puddey IB, Klag MJ. Risk of end-stage renal disease
  87. associated with alcohol consumption. Am J Epidemiol 1999; 150: 1275–1281.
  88. White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol
  89. consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol
  90. Dial Transplant 2009; 24: 2464–2472.
  91. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006 Aug 1;164(3):263-71. doi: 10.1093/aje/kwj173.
  92. Cooper RG. Effect of tobacco smoking on renal function. Indian J Med Res. 2006;124(3):261-8.
  93. Ling L, Yang M, Ding W, Gu Y. Ghrelin attenuates UUO-induced renal fibrosis via attenuation of Nlrp3 inflammasome and endoplasmic reticulum stress. Am J Transl Res. 2019;11(1):131-141.
  94. Jamieson LM, Thomson WM. Xerostomia: its prevalence and associations in the adult Australian population. Aust Dent J. 2020;65 Suppl 1:S67-S70. doi: 10.1111/adj.12767.
  95. Laheij A, Rooijers W, Bidar L, Haidari L, Neradova A, de Vries R, Rozema F. Oral health in patients with end-stage renal disease: A scoping review. Clin Exp Dent Res. 2022;8(1):54-67. doi: 10.1002/cre2.479.
  96. Bossola M, Tazza L. Xerostomia in patients on chronic hemodialysis. Nat Rev Nephrol. 2012;8(3):176-82. doi: 10.1038/nrneph.2011.218. PMID: 22249779.
  97. Silva DF, Ramos Oliveira IC, Medeiros S, Baeder FM, Lyra de Albuquerque AC, Lima EO, Oral health challenges in patients with chronic kidney disease: A comprehensive clinical assessment. The Saudi Dental Journal, 2023, https://doi.org/10.1016/j.sdentj.2023.11.026.
  98. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765.
  99. Chang Y, Lee JS, Woo HG, Ryu DR, Kim JW, Song TJ. Improved oral hygiene care and chronic kidney disease occurrence: A nationwide population-based retrospective cohort study. Medicine (Baltimore). 2021;100(47):e27845. doi: 10.1097/MD.0000000000027845.
  100. Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, de la Sierra A, de la Cruz JJ, Vinyoles E, Divisón-Garrote JA, Segura J, Banegas JR. Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients. J Hypertens. 2018;36(5):1076-1085. doi: 10.1097/HJH.0000000000001670.
  101. Grubbs V, Vittinghoff E, Beck JD, Kshirsagar AV, Wang W, Griswold ME, Powe NR, Correa A, Young B. Association Between Periodontal Disease and Kidney Function Decline in African Americans: The Jackson Heart Study. J Periodontol. 2015;86(10):1126-32. doi: 10.1902/jop.2015.150195.

Similar Articles

1-10 of 196

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)